OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
Christian Karime, Jing Wang, Gregory Woodhead, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 31, Iss. 1, pp. 1-13
Closed Access | Times Cited: 9
Christian Karime, Jing Wang, Gregory Woodhead, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 31, Iss. 1, pp. 1-13
Closed Access | Times Cited: 9
Showing 9 citing articles:
Targeting the innate immune system in pediatric and adult AML
Alicia Perzolli, Joost B. Koedijk, C. Michel Zwaan, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1191-1201
Open Access | Times Cited: 11
Alicia Perzolli, Joost B. Koedijk, C. Michel Zwaan, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1191-1201
Open Access | Times Cited: 11
Engineered macromolecular Toll-like receptor agents and assemblies
Brooke A. Jackson Hoffman, Elizabeth A. Pumford, Amaka I. Enueme, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 9, pp. 1139-1154
Open Access | Times Cited: 15
Brooke A. Jackson Hoffman, Elizabeth A. Pumford, Amaka I. Enueme, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 9, pp. 1139-1154
Open Access | Times Cited: 15
TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity
Shuting Wu, Rong Xiang, Yiwei Zhong, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Shuting Wu, Rong Xiang, Yiwei Zhong, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
Linyinxue Dong, Xuechen Tian, Yunqi Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14775-14775
Open Access | Times Cited: 19
Linyinxue Dong, Xuechen Tian, Yunqi Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14775-14775
Open Access | Times Cited: 19
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Juan Bautista De Sanctis, Jaime Charris, Zuleyma Blanco, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 10, pp. 1122-1144
Closed Access | Times Cited: 18
Juan Bautista De Sanctis, Jaime Charris, Zuleyma Blanco, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 10, pp. 1122-1144
Closed Access | Times Cited: 18
Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
Run Zheng, Jian Ma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2285-2285
Open Access | Times Cited: 18
Run Zheng, Jian Ma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2285-2285
Open Access | Times Cited: 18
Intratumoral Immunotherapy: Is It Ready for Prime Time?
Mario Ghosn, Lambros Tselikas, Stéphane Champiat, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 8, pp. 857-867
Closed Access | Times Cited: 10
Mario Ghosn, Lambros Tselikas, Stéphane Champiat, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 8, pp. 857-867
Closed Access | Times Cited: 10
Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
Shamar Young, Jack Hannallah, Dan Goldberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11434-11434
Open Access | Times Cited: 5
Shamar Young, Jack Hannallah, Dan Goldberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11434-11434
Open Access | Times Cited: 5
Targeting leukemia inhibitory factor in pancreatic adenocarcinoma
Jing Wang, Christian Karime, Umair Majeed, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 387-399
Closed Access | Times Cited: 1
Jing Wang, Christian Karime, Umair Majeed, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 387-399
Closed Access | Times Cited: 1
